je.st
news
Pershing Square names Allergan board candidates
2014-07-07 21:17:06| Biotech - Topix.net
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International Inc. want to buy Allergan and have offered $72 per share, or about $53 billion in cash and stock, for the company.
Tags: board
names
square
candidates
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||